HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization - Valle-Millares D; Brochado-Kith Ó; Gómez-Sanz A; Martín-Carbonero L; Ryan P; De Los Santos I; Castro JM; Troya J; Mayoral-Muñoz M; Cuevas G; Martínez-Román P; Sanz-Sanz J; et al. (Biomedicine & Pharmacotherapy, 2021)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients - Brochado Ó; Martínez I; Berenguer J; Medrano L; González-García J; Jiménez-Sousa MÁ; Carrero A; Hontañón V; Navarro J; Guardiola JM; Fernández-Rodríguez A; Resino S; (Journal Of Biomedical Science, 2021)

PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study - Salgüero S; Brochado-Kith Ó; Verdices AV; Berenguer J; González-García J; Martínez I; Díez C; Hontañón V; Pérez-Latorre L; Fernández-Rodríguez A; Jiménez-Sousa MÁ; Resino S (Biomedicine & Pharmacotherapy, 2023)

Plasma miRNA-Metabolite Dysregulation in People with HIV with Cirrhosis Despite Successful HCV Cure. - Virseda-Berdices A; Behar-Lagares R; Berenguer J; González-García J; Requena B; Brochado-Kith O; Díez C; Hontañon V; Grande-García S; González-Riano C; Barbas C; Resino S; et al. (Pharmaceuticals, 2026)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients. - Virseda-Berdices A; Brochado-Kith Ó; Berenguer J; González-García J; Pérez-Latorre L; Busca C; Díez C; Micán R; Fernández-Rodríguez A; Jiménez-Sousa MÁ; Resino S (Frontiers In Pharmacology, 2024)

Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis. - Virseda-Berdices A; Brochado-Kith O; Díez C; Hontañon V; Berenguer J; González-García J; Rojo D; Fernández-Rodríguez A; Ibañez-Samaniego L; Llop-Herrera E; Olveira A; Perez-Latorre L; et al. (Journal Of Antimicrobial Chemotherapy, 2022)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients. - Brochado-Kith Ó; Martínez I; Berenguer J; González-García J; Salgüero S; Sepúlveda-Crespo D; Díez C; Hontañón V; Ibañez-Samaniego L; Pérez-Latorre L; Fernández-Rodríguez A; Ángeles Jiménez-Sousa M; et al. (Frontiers In Immunology, 2021)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals. - Molina-Carrión S; Brochado-Kith Ó; González-García J; Berenguer J; Díez C; Llop E; Hontañón V; Ibañez-Samaniego L; Montes ML; Resino S; Fernández-Rodríguez A; Jiménez-Sousa MÁ (Journal Of Clinical Medicine, 2020)